Skystar Bio-pharmaceutical Co (SKBI) financial statements (2021 and earlier)

Company profile

Business Address RM 10601, JIEZUO PLAZA, NO. 4
XIAN PROVINCE, 00000
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments151678464
Cash and cash equivalents151678464
Restricted cash and investments77     
Receivables42261911271213
Inventory, net of allowances, customer advances and progress billings23242526272724
Inventory23242526272724
Prepaid expense222223 
Advances on inventory purchases28384141283233
Deposits current assets000001 
Prepaid expense and other current assets3
Deferred tax assets10000  
Other undisclosed current assets3(7)(6)(0)(0)(0) 
Total current assets:1211078889898076
Noncurrent Assets
Property, plant and equipment30303028292929
Intangible assets, net (including goodwill)5555555
Intangible assets, net (excluding goodwill)5555555
Prepaid expense255551 
Prepaid expense and other noncurrent assets1
Other undisclosed noncurrent assets(26)(27)(30)(28)(28)(29)(29)
Total noncurrent assets:101310101077
Other undisclosed assets40373738383837
TOTAL ASSETS:172157135136136124120
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities171185937
Accounts payable9653425
Accrued liabilities 0000  
Taxes payable8431512
Debt11811861111117
Due to related parties3321211
Customer advances and deposits22 
Other undisclosed current liabilities(92)(92)88766
Total current liabilities:48422425282120
Noncurrent Liabilities
Liabilities, other than long-term debt1111111
Deferred revenue and credits1111111
Derivative instruments and hedges, liabilities  000 0
Other undisclosed noncurrent liabilities      1
Total noncurrent liabilities:1111112
Total liabilities:49432526292223
Stockholders' equity
Stockholders' equity attributable to parent, including:12311411011010710397
Preferred stock0      
Common stock0000000
Additional paid in capital42383838373737
Accumulated other comprehensive income1111111211119
Retained earnings64595655534945
Other undisclosed stockholders' equity attributable to parent6666666
Total stockholders' equity:12311411011010710397
TOTAL LIABILITIES AND EQUITY:172157135136136124120

Income statement (P&L) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Revenues181471016116
Revenue, net181471016116
Cost of revenue
(Cost of Goods and Services Sold)
(10)(8)(4)(5)(9)(6)(3)
Other undisclosed gross profit1100100
Gross profit:9635863
Operating expenses(3)(3)(2)(2)(3)(1)(2)
Operating income:5313551
Nonoperating income (expense)0000(0)(0)(0)
Investment income, nonoperating 0(0)0(0)00
Other nonoperating income (expense)00000(0)(0)
Interest and debt expense(0)(0)     
Income from continuing operations before equity method investments, income taxes:5313541
Other undisclosed income from continuing operations before income taxes00     
Income from continuing operations before income taxes:6313541
Income tax expense(1)(1)(0)(1)(1)(1)(0)
Net income available to common stockholders, diluted:5312441

Comprehensive Income ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net income:5312441
Comprehensive income:5312441
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(1)0121
Comprehensive income, net of tax, attributable to parent:5303451

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: